Two Categories of Bipolar Disorder That Can Change Treatment
DSM focuses on the difference between Bipolar I and II. But there’s another way to categorize the illness that may have more relevance to treatment.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
SUBSCRIBE: eNewsletter
DSM focuses on the difference between Bipolar I and II. But there’s another way to categorize the illness that may have more relevance to treatment.
An environmental approach to mania makes it possible to “slow down the sun” and modulate the destabilizing effects of spring sunlight. More in this report.
Lamotrigine’s favorable tolerability is a welcome advance for patients with bipolar disorder. The danger it poses is at the start of treatment, when its mood-lifting effects can easily be waylaid by the eruption of a rash.
Lamotrigine has unique benefits that are often missed in practice. Learn when to use it—and when to avoid it—in this tutorial.
Among the topics covered in this year's noteworthy studies: lithium and suicide prevention, mixed depression, and light therapy.
Six patient types to watch for.
A novel protocol lights the way for a promising treatment for bipolar depression.
Although supported by basic science, it’s still a sea change to think that diet can treat depression. A new clinical trial puts that idea to the test.
Most of the adverse effects of lithium are manageable—and a little knowledge goes a long way.
Not just a nuisance, no-shows are an opportunity to turn things around for patients with bipolar disorder, whose treatment adherence hovers around 60%.